» Articles » PMID: 24695224

MTH1 Inhibition Eradicates Cancer by Preventing Sanitation of the DNTP Pool

Abstract

Cancers have dysfunctional redox regulation resulting in reactive oxygen species production, damaging both DNA and free dNTPs. The MTH1 protein sanitizes oxidized dNTP pools to prevent incorporation of damaged bases during DNA replication. Although MTH1 is non-essential in normal cells, we show that cancer cells require MTH1 activity to avoid incorporation of oxidized dNTPs, resulting in DNA damage and cell death. We validate MTH1 as an anticancer target in vivo and describe small molecules TH287 and TH588 as first-in-class nudix hydrolase family inhibitors that potently and selectively engage and inhibit the MTH1 protein in cells. Protein co-crystal structures demonstrate that the inhibitors bind in the active site of MTH1. The inhibitors cause incorporation of oxidized dNTPs in cancer cells, leading to DNA damage, cytotoxicity and therapeutic responses in patient-derived mouse xenografts. This study exemplifies the non-oncogene addiction concept for anticancer treatment and validates MTH1 as being cancer phenotypic lethal.

Citing Articles

Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.

Adler A, Bergwik J, Padra M, Papareddy P, Schmidt T, Dahlgren M Respir Res. 2025; 26(1):101.

PMID: 40087604 DOI: 10.1186/s12931-025-03175-z.


MTH1 in the disorders of the central nervous system: scope beyond brain tumors and challenges.

Padmakumar L, Menon R, Gopala S, Vilanilam G Acta Neurol Belg. 2025; .

PMID: 39960601 DOI: 10.1007/s13760-025-02747-6.


Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.

Valerie N, Sanjiv K, Mortusewicz O, Zhang S, Alam S, Pires M Nat Commun. 2024; 15(1):10347.

PMID: 39643609 PMC: 11624193. DOI: 10.1038/s41467-024-54415-7.


Role of MTH1 in oxidative stress and therapeutic targeting of cancer.

Taiyab A, Ashraf A, Sulaimani M, Rathi A, Shamsi A, Hassan M Redox Biol. 2024; 77:103394.

PMID: 39418911 PMC: 11532495. DOI: 10.1016/j.redox.2024.103394.


The roles of patient-derived xenograft models and artificial intelligence toward precision medicine.

Janitri V, Aruljothi K, Ravi Mythili V, Singh S, Prasher P, Gupta G MedComm (2020). 2024; 5(10):e745.

PMID: 39329017 PMC: 11424683. DOI: 10.1002/mco2.745.


References
1.
Rai P, Young J, Burton D, Giribaldi M, Onder T, Weinberg R . Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence. Oncogene. 2010; 30(12):1489-96. DOI: 10.1038/onc.2010.520. View

2.
. Measurement of DNA oxidation in human cells by chromatographic and enzymic methods. Free Radic Biol Med. 2003; 34(8):1089-99. DOI: 10.1016/s0891-5849(03)00041-8. View

3.
Murshudov G, Vagin A, Dodson E . Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr. 1997; 53(Pt 3):240-55. DOI: 10.1107/S0907444996012255. View

4.
Farmer H, McCabe N, Lord C, Tutt A, Johnson D, Richardson T . Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005; 434(7035):917-21. DOI: 10.1038/nature03445. View

5.
Hahn W, Counter C, Lundberg A, Beijersbergen R, Brooks M, Weinberg R . Creation of human tumour cells with defined genetic elements. Nature. 1999; 400(6743):464-8. DOI: 10.1038/22780. View